Fiduciary Trust International Appoints Miles Powell as Washington, DC-Based Regional Managing Director

Fiduciary Trust International Appoints Miles Powell as Washington, DC-Based Regional Managing Director

WASHINGTON–(BUSINESS WIRE)–
Fiduciary Trust International, a global wealth manager and wholly-owned subsidiary of Franklin Templeton, announces that Miles Powell has joined the firm as regional managing director and senior relationship manager based in Washington, DC.

“Fiduciary Trust International has been committed to the Washington, DC market for many years, and we are thrilled to continue to add talent to our deeply experienced team,” said Lawrence A. Sternkopf, president and chief operating officer of Fiduciary Trust International. “Miles combines collaborative leadership with an in-depth understanding of how various aspects of financial services can meet client needs, which will be crucial as we continue to expand our office in the nation’s capital.”

“The Washington, DC area is a growing marketplace with many high-net-worth individuals and families, as well as philanthropic endowments and foundations,” said Bill Leffingwell, CFP®, who continues to serve as senior portfolio manager in Fiduciary Trust International’s Washington, DC office. “Miles has the experience and expertise that will help us continue to strengthen our offering in this marketplace.”

Mr. Powell, who reports to Mr. Sternkopf, will also oversee Fiduciary Trust International’s office in Arlington, VA. He comes to Fiduciary Trust International from Wells Fargo Private Bank in McLean, VA, where he served as managing director and senior director of investment and fiduciary services for more than a decade. In that role, Mr. Powell was responsible for the performance of the firm’s investment and fiduciary business in the Mid-Atlantic region. Previously, he was senior vice president and market trust executive at Bank of America Private Bank. Earlier in his career, Mr. Powell was senior vice president and corporate sales director at Riggs Bank.

“Fiduciary Trust International has a well-deserved reputation across the country for working closely with clients to customize wealth management strategies and solutions that can help them meet long-term goals,” said Mr. Powell. “For 90 years, this organization has been committed to providing clients and their families with financial peace of mind—something that is especially important during this time. I look forward to working with my new colleagues to deliver holistic wealth management across generations.”

Mr. Powell is a past president of the Washington, DC Estate Planning Council. He graduated from The College of William & Mary with a BA in Economics.

About Fiduciary Trust International

Fiduciary Trust International, a global wealth management firm headquartered in New York, NY, has served individuals, families, endowments and foundations since 1931. With over $86 billion in assets under management and administration as of September 30, 2020, the firm specializes in strategic wealth planning, investment management and trust and estate services, as well as tax and custody services. The New York-based firm and its subsidiaries maintain offices in Coral Gables, FL, Boca Raton, FL, St. Petersburg, FL, Radnor, PA, Lincoln, MA, Los Angeles, CA, San Mateo, CA, San Francisco, CA, Washington, DC, Wilmington, DE, and Arlington, VA. For more information, please visit fiduciarytrust.com, and for the latest updates, follow Fiduciary Trust International on LinkedIn and Twitter: @FiduciaryTrust.

About Franklin Templeton

Franklin Resources, Inc. [NYSE: BEN], is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 165 countries. Franklin Templeton’s mission is to help clients achieve better outcomes through investment management expertise, wealth management and technology solutions. Through its specialist investment managers, the company brings extensive capabilities in equity, fixed income, multi-asset solutions and alternatives. With offices in more than 30 countries and approximately 1,300 investment professionals, the California-based company has over 70 years of investment experience and approximately $1.5 trillion in assets under management as of November 30, 2020. For more information, please visit franklintempleton.com and follow us on LinkedIn, Twitter and Facebook.

Copyright © 2021. Fiduciary Trust International. All rights reserved.

Rebecca Radosevich: 212-632-3207

[email protected]

Laura Simpson: 973-713-8834

[email protected]

KEYWORDS: District of Columbia United States North America

INDUSTRY KEYWORDS: Consulting Accounting Professional Services Finance

MEDIA:

Wolters Kluwer Health Announces Integration of its Clinical Interface Terminology Solutions with Henry Schein MicroMD’s EMR Platform

Wolters Kluwer Health Announces Integration of its Clinical Interface Terminology Solutions with Henry Schein MicroMD’s EMR Platform

“Google Translate for Clinician-Speak” Can Help Improve Clinical Documentation Accuracy with Smarter Problem and Diagnosis Search

WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer Health announced today that Henry Schein MicroMD, a practice management and electronic medical record (EMR) solution, will be using Health Language Clinical Interface Terminology (CIT) to quickly map over a million medical abbreviations, typos, incomplete terms, and acronyms to standardized terminology. As a result, clinicians using MicroMD can easily search for diagnoses and procedure codes using their own day-to-day jargon with Wolters Kluwer Health Language Provider-Friendly Terminology (PFT).

“Unspecified diagnosis codes can have a significant financial impact for a medical practice. To avoid revenue loss, it’s critical that patient encounters be documented correctly at the point of care,” said Kristen Heffernan, General Manager at MicroMD, a Henry Schein company. “The integration of Wolters Kluwer’s provider-friendly terminology solutions can help enable clinicians to document more quickly and accurately, help reduce rejected claims, and help increase patient time with their providers.”

Health Language PFT is built upon tools that deliver a computer-processable collection of medical terms providing codes, terms, synonyms and definitions used in clinical documentation and reporting, such as ICD-10-CM, ICD-9-CM, and SNOMED CT®. Sophisticated search algorithms convert a clinician’s problem or diagnosis search into a standard, compliant code using a continually updated array of related terms, including synonyms, misspellings, word order variants and partial words. For example, clinicians using MicroMD can search familiar clinical shorthand or jargon such as AFib, A-Fib, atrial fib, or AF and PFT will consistently provide the corresponding ICD or SNOMED CT codes for atrial fibrillation.

“Our technology solution uses more than 300,000 attributes to help clinicians navigate the complexities of ICD-10 and pinpoint appropriate codes,” said Karen Kobelski, Vice President and General Manager, Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer Health. “With just a few clicks, clinicians are able to narrow 1,000 ICD-10 codes down to the one they need using their own terms. This significantly improves the physician documentation experience and the accuracy of the revenue cycle.”

For medical practices, PFT can improve clinical documentation, increase clinicians’ satisfaction with their EHR, support clinician productivity and reduce revenue losses associated with inaccurate or incomplete clinical documentation. To learn more about how Wolters Kluwer Clinical Interface Terminology solutions can help improve your medical practice, please click here.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

André Rebelo

Public Relations Manager

Wolters Kluwer

+1 781.392.2411

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Professional Services Medical Devices Health Technology Software Consulting

MEDIA:

Logo
Logo

2020 Canadian IPO mixed results – number (77) down, amount ($5.55B) up driven by PE-backed IPOs

Canada NewsWire

TORONTO, Jan. 5, 2021 /CNW/ – While the US initial public offering (IPO) and special purpose acquisition corporation (SPAC) market experienced an unprecedent boom in 2020, Canadian IPO market continued to struggle with mixed results.

77 IPOs including capital pool companies (CPCs) and SPACs were completed in 2020 on four Canadian stock exchanges, raising $5.55 billion in aggregate gross proceeds, or excluding CPCs and SPACs, 43 IPOs for $4.85 billion.

The 2020 IPO numbers represent a decrease of 29% in total number of IPOs and an increase of 116% in total amount or, excluding CPC/SPAC IPOs, a decrease of 7% in total IPO number and an increase of 605% in total amount from 2019.

Excluding CPC/SPAC IPOs, CSE continues to lead all Canadian exchanges with 25 IPOs (58%), comparing to 31 IPOs (67%) in 2019. 

Mining issuers led all sectors with 23 IPOs for $324 million, accounting for 53% and 7% of the total number of Non-CPC/SPAC IPOs and total amount respectively.

4 Private Equity (PE) and 2 Venture Capital (VC) backed IPOs dominated the total amount, raising $3,395 million and $144 million respectively, or $3,539 million in aggregate, representing 64% of total IPO amount or 73% of total Non-CPC/SPAC IPO amount.

2020 IPO Breakdown by Exchanges (Non-CPC/SPAC)

  • CSE – 25 IPOs for $43 million (25 IPOs for $43 million)
  • TSX – 11 IPO for $4,726 million (10 IPOs for $4,460 million)
  • TSX Venture Exchange – 39 IPOs for $364 million (8 IPOs for $350 million)
  • NEO – 2 IPOs for $421 million (nil)

2020 Canadian IPOs League Table – Top 8 Law Firms (by # IPOs only)

All IPO Ranking (#, $total IPO value)

  1. Miller Thomson LLP (13, $17M)
  2. Blake, Cassels & Graydon LLP (11, $1,549M)
  3. DuMoulin Black LLP (8, $17M)
  4. Cassels Brock & Blackwell LLP (7, $38M)
  5. Harper Grey LLP (7, $10M)
  6. MLT Aikins LLP (7, $5M)
  7. Peterson McVicar LLP (7, $2M)
  8. Borden Ladner Gervais LLP (6, $12M)

Non-CPC/SPAC IPO Ranking (#, $total IPO value)

  1. Blake, Cassels & Graydon LLP (8, $861M)
  2. Miller Thomson LLP (7, $16M)
  3. Stikeman Elliott LLP (5, $2,165M)
  4. DuMoulin Black LLP (5, $16M)
  5. Harper Grey LLP (5, $10M)
  6. Cassels Brock & Blackwell LLP (4, $37M)
  7. Vantage Law Corporation (4, $6M)
  8. Lotz & Company (4, $2M)

2020 Canadian IPOs League Table – Top 13 Underwriters (by # IPOs Only)

All IPO Ranking (#, $total IPO value)

  1. Canaccord Genuity Corp. (26, $2,535M)
  2. Haywood Securities Inc. (24, $ 25M)
  3. BMO Nesbitt Burns Inc. (12, $ 4,651M)
  4. Scotia Capital Inc. (9, $4,349M)
  5. CIBC World Markets Inc. (8, $4,372M)
  6. Leede Jones Gable Inc. (8, $12M)
  7. Raymond James Ltd. (7, $4,053M)
  8. TD Securities Inc. (7, $4,045M)
  9. National Bank Financial Inc. (7, $4,039M)
  10. Industrial Alliance Securities Inc. (7, $1,017M)
  11. Mackie Research Capital Corporation (7, $9M)
  12. RBC Dominion Securities Inc. (6, $4,006M)
  13. Stifel Nicolaus Canada Inc. (6, $3,623M)

Non-CPC/SPAC IPO Ranking (#, $total IPO value)

  1. Canaccord Genuity Corp. (17, $1,846M)
  2. BMO Nesbitt Burns Inc. (12, $4,651M)
  3. Haywood Securities Inc. (9, $20M)
  4. Scotia Capital Inc. (9, $4,349M)
  5. CIBC World Markets Inc. (8, $4,372M)
  6. Raymond James Ltd. (7, $4,053M)
  7. TD Securities Inc. (7, $4,045M)
  8. National Bank Financial Inc. (7, $4,039M)
  9. RBC Dominion Securities Inc. (6, $4,006M)
  10. Stifel Nicolaus Canada Inc. (6, $3,623M)
  11. Leede Jones Gable Inc. (6, $12M)
  12. Mackie Research Capital Corporation (6, $8M)
  13. Desjardins Securities Inc.  (5, $952M)

2020 Top Five Canadian IPOs (Canadian and foreign exchanges)
Three of top five Canadian IPOs were done on the NASDAQ Exchange. The Top Five are backed either by private equity or venture capital firms.


Issuer


Backed

Close Date

$ Raised (Mil)

Exchange(s)

Valuation* ($Mil)

GFL Environmental Inc.

PE

2020-03-05

$1,425 (US)

TSX/NYSE: GFL

$6,416 (US)

Nuvei Corporation

PE

2020-09-22

$805 (US)

TSX: NVEI

$3,390 (US)

AbCellera Biologics Inc.

VC

2020-12-15

$555 (US)

NASDAQ: ABCL

$5,384 (US)

Repare Therapeutics Inc.

VC

2020-06-23

$253 (US)

NASDAD: RPTX

$700 (US)

Fusion Pharmaceuticals Inc.

VC

2020-06-30

$213 (US)

NASDAQ: FUSN

$708 (US)

Report Summary
2020 Canadian IPO Report Summary can be downloaded from financings.cahttps://www.financings.ca/reports/

About CPE Analytics

CPE Analytics, through financings.ca, is Canada’s all public and private financing data provider. We offer comprehensive data coverage and analysis on private capital and public financings, IPOs, M&As and VC/PE fundraising. More information:  https://cpeanalytics.ca

CPE Analytics is a division of CPE Media Inc., Canada’s all financing news and data provider.

SOURCE CPE Media Inc.

Inpixon Releases Enhanced Inpixon Aware Security Solution

Delivers Advanced UWB, Cellular, Wi-Fi, Bluetooth Device Detection and Positioning Capabilities for Global Enterprises, Financial Institutions, Legal Firms, Government and Other Organizations With High-Security Requirements

PR Newswire

PALO ALTO, Calif., Jan. 5, 2021 /PRNewswire/ — Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today announced its latest release of Inpixon Aware, the company’s indoor security solution. The award-winning Inpixon Aware provides organizations with a highly-scalable situational awareness and wireless detection solution within a single, near real-time dashboard enabling management to make key decisions around security, risk mitigation and safety. The latest version, Inpixon Aware 5.17, includes improved ultra-wideband (UWB) wireless device detection and positioning, advanced mitigation of RF noise, IPv6 support for the latest generation of Inpixon sensors, and additional enhancements.

Inpixon Aware, previously known as ZoneDefense, is designed to help corporate enterprises and governmental agencies combat theft of confidential information and to enhance safety and operational efficiency by providing visibility into the location of wireless devices, people and critical assets within indoor spaces. Inpixon Aware uses radio frequency (RF) sensors to detect and locate active Wi-Fi, Bluetooth, cellular and UWB wireless transmissions emanating from phones, smartwatches, tablets, computers, access points, IoT devices and more. Security personnel can locate unauthorized wireless devices, enforce no-phones zones, geofence areas to receive alerts when devices move into and out of the zones, trigger mobile device management (MDM) policies that restrict usage in high-security areas, and whitelist wireless medical devices such as hearing aids and pacemakers. The solution can also be utilized to monitor the location of visitors to the facility and to locate key personnel and assets in order to enhance security and situational awareness.

Nadir Ali, Inpixon CEO noted, “Security-conscious organizations including global enterprises, financial institutions, legal firms, transportation companies, and government agencies can use Inpixon Aware to discover wireless listening devices placed by bad actors, locate unescorted visitors, pinpoint cell phone use in unauthorized areas, and uncover unauthorized wireless access points brought into the office by employees. These capabilities and others can enhance the security posture, improve incident response, facilitate investigations, and reduce manpower requirements. The release of our latest enhancements reinforces our commitment to staying at the forefront of the industry and providing customers the most comprehensive security solution to assist organizations in making key decisions to create a safer and secure environment for personnel, visitors and assets.”

About Inpixon

Inpixon® (Nasdaq: INPX) is the Indoor Intelligence™ company that specializes in capturing, interpreting and giving context to indoor data so it can be translated into actionable intelligence. The company’s Indoor Intelligence platform ingests diverse data from IoT, third-party and proprietary sensors designed to detect and position active cellular, Wi-Fi, UWB and Bluetooth devices. Paired with a high-performance data analytics engine, patented algorithms, and advanced mapping technology, Inpixon’s solutions are leveraged by a multitude of industries to do good with indoor data. This multidisciplinary depiction of indoor data enables users to increase revenue, decrease costs, and enhance safety. Inpixon customers can boldly take advantage of location awareness, analytics, sensor fusion and the Internet of Things (IoT) to uncover the untold stories of the indoors. For the latest insights, follow Inpixon on LinkedInTwitter, and visit inpixon.com.

Safe Harbor Statement

All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of Inpixon and its subsidiaries, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of economic conditions, the impact of COVID-19 on Inpixon’s results of operations, Inpixon’s ability to integrate the products and business from recent acquisitions into its existing business, the performance of management and employees, the regulatory landscape as it relates to privacy regulations and their applicability to Inpixon’s technology, Inpixon’s ability to maintain compliance with Nasdaq’s minimum bid price requirement and other continued listing requirements, including during a panel monitoring period ending on February 5, 2021, the ability to obtain financing, competition, general economic conditions and other factors that are detailed in Inpixon’s periodic and current reports available for review at sec.gov. Furthermore, Inpixon operates in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. Inpixon disclaims any intention to, and undertakes no obligation to, update or revise forward-looking statements.

Inpixon Contacts

Media relations and general inquiries:
Inpixon
Email: [email protected]
Web: inpixon.com/contact-us

Investor relations:
Crescendo Communications, LLC
Tel: +1 212-671-1020
Email: [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/inpixon-releases-enhanced-inpixon-aware-security-solution-301201040.html

SOURCE Inpixon

Therapeutic Solutions International Reports QuadraMune™ Administration Enhances T Cytotoxic Responses in Mouse Model of Adaptive Immunity

Company Continues Elucidation of Immunological Mechanisms of QuadraMune™ Nutraceutical Currently in Clinical Trials for COVID-19 Prevention

PR Newswire

OCEANSIDE, Calif., Jan. 5, 2021 /PRNewswire/ — Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data from its ongoing investigations into the immunological mechanisms by which QuadraMune™ functions as a potential antiviral nutraceutical. 

In mice receiving QuadraMune™ for a period of two weeks, a significantly increased cytotoxic T cell response was seen after immunization with proteins that resemble virally associated proteins.  T cytotoxic cells are a component of the immune system which selectively kills virally infected cells.  Successful immunity to viruses is dependent on T cytotoxic cell activity.

“Last week we reported data that QuadraMune™ increases Th1 cell activity, which orchestrates antiviral immunity.  This week we demonstrated that QuadraMune™ increases T cytotoxic cell activity.  The T cytotoxic cell being the actual effector cells of adaptive antiviral immunity,” said Dr. James Veltmeyer, Chief Medical Officer of the Company. “The fact that we are using natural ingredients to boost up various components of the immune system that are needed to fight viruses makes us confident in the outcome of our ongoing COVID-19 prevention clinical trial.”

“While many of our colleagues are scrambling to utilize synthetic immune stimulants, whose long-term consequences are not well understood, we are excited to be leveraging natural ingredients such as nigella sativa, whose therapeutic effects have been well described in the literature for thousands of years,” said Famela Ramos, Vice President of Business Development. “To my knowledge we are one of the only companies that is actually leveraging modern day immunological sciences to optimize herbal compositions and remedies.”

“Through understanding the cellular and molecular mechanisms by which QuadraMune™ works, we are confident in the rapid acceptance of our nutraceutical by the medical community as a natural approach to boosting the proper immunity needed to fight off viruses,” stated Timothy Dixon, President and CEO of the Company.  “Combined with the known effects of QuadraMune ingredients in suppressing the NLRP3 inflammasome pathway, we believe that our scientists have developed a ‘first in class’ nutraceutical to potentially address both immune deficiency and hyperinflammation associated with COVID-19.”

About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company’s corporate website is www.therapeuticsolutionsint.com, and our public forum is https://board.therapeuticsolutionsint.com/.

CONTACT:  [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/therapeutic-solutions-international-reports-quadramune-administration-enhances-t-cytotoxic-responses-in-mouse-model-of-adaptive-immunity-301201036.html

SOURCE Therapeutic Solutions International

Russel Metals 2020 Year End and Fourth Quarter Results Conference Call

PR Newswire


NOTICE

TORONTO, Jan. 5, 2021 /PRNewswire/ – The Company’s results for the 2020 year end and fourth quarter will be issued by press release on Wednesday, February 10, 2021 after the close of business at 5:00 p.m. ET.

An Investor Conference Call will be hosted by Martin L. Juravsky, Executive Vice President and Chief Financial Officer and John G. Reid, President and Chief Executive Officer on Thursday, February 11, 2021 at 9:00 a.m. ET to review the results.

The dial-in telephone numbers for the call are 416-764-8688 (Toronto and International callers) and 1-888-390-0546 (U.S. and Canada). Please dial in 10 minutes prior to the call to ensure that you get a line.

A replay of the call will be available at 416-764-8677 (Toronto and International callers) and 1-888-390-0541 (U.S. and Canada) until midnight, Thursday, February 25, 2021. You will be required to enter pass code 972349# in order to access the call.

If you would like to unsubscribe from receiving notices of our Investor Quarterly Conference Calls, you may do so by emailing [email protected]; or by calling our Investor Relations Line: 905-816-5178.

If you have any additional questions, please contact our Investor Relations Department at [email protected] or 905-816-5178.

Website:  www.russelmetals.com

Cision View original content:http://www.prnewswire.com/news-releases/russel-metals-2020-year-end-and-fourth-quarter-results-conference-call-301201101.html

SOURCE Russel Metals Inc.

Farmer sentiment rises as income prospects improve, concerns about key policy issues remain

PR Newswire

WEST LAFAYETTE, Ind. and CHICAGO, Jan. 5, 2021 /PRNewswire/ — There was a modest improvement in producer sentiment according to the December Purdue University/CME Group Ag Economy Barometer. The barometer increased 7 points from November to a reading of 174. Both of the barometer’s sub-indices, the Index of Current Conditions and the Index of Future Expectations, were also higher in December than in November. The Index of Current Conditions climbed 15 points to 202 and the Index of Future Expectations increased by 5 points to a reading of 161. The Ag Economy Barometer is calculated each month from 400 U.S. agricultural producers’ responses to a telephone survey. This month’s survey was conducted from December 7-11, 2020.

“The rise in the Ag Economy Barometer was primarily driven by farmers’ perception that the current situation on their farms really improved. The sharp rise in the Index of Current Conditions is correlated with the farm income boost provided by the ongoing rally in crop prices. That appears to be the driving force behind producers’ optimism,” said James Mintert, the barometer’s principal investigator and director of Purdue University’s Center for Commercial Agriculture.

Producers were noticeably more inclined to think now is a good time to make large investments in their farming operations than in November. The Farm Capital Investment Index increased 13 points in December to a record high of 93. The percentage of farmers expecting to increase their machinery purchases in the upcoming year rose 5 points to 15 percent in December, while the percentage expecting to reduce their purchases declined by the same amount.

They were also bullish about farmland values and cash rental rates. In December, the percentage of farmers expecting farmland values to rise over the next year increased 9 points from November to a reading of 35. The percentage expecting farmland values to rise over the next five years increased 11 points from November to a life of survey high 65 percent.

Reflecting the improvement in crop production profitability, more producers said they expect farmland cash rental rates to rise in 2021 when compared to survey results from late summer. In December, 18 percent of respondents said they expect cash rental rates to rise in 2021, double the percentage who felt that way in August and September. Moreover, it’s clear that any downward pressure on cash rental rates evident earlier in the year has nearly disappeared, as just 5 percent of farmers said they expect to see cash rental rates decline in 2021 compared to 17 percent who felt that way in August.

Farmers were less optimistic when asked about the on-going trade dispute between U.S. and China. In the first quarter of 2020, an average of 76% of respondents thought the trade dispute’s ultimate resolution would favor U.S. agriculture, by spring that average declined to 62 percent, and by December it dropped to an all-time survey low of 47 percent. When asked whether they expect U.S. ag exports to increase over the next five years, only 51 percent of respondents in December said they expect to see export growth.

To learn more about what factors might be motivating the shift in producers’ sentiment pre- and post-November election, a series of questions focused on producers’ future expectations for environmental regulations, taxes and other key aspects of the agricultural economy, were included on the October, November and December surveys. In December, farmers continued to express concerns following the November election about several key policy issues affecting agriculture. Over 80 percent of farmers said they expect environmental regulations to become more restrictive in December, compared to 41 percent who felt that way in October. Over 70 percent of producers expect to see higher income and estate taxes compared to 35 and 40 percent, respectively, in October. One-third of farmers said they expect the farm income safety net to weaken compared to 18 percent and just over one-fourth of producers said they expect government support for the ethanol industry to weaken compared to 17 percent who felt that way in October.

Read the full Ag Economy Barometer report at https://purdue.ag/agbarometer. The site also offers additional resources – such as past reports, charts and survey methodology – and a form to sign up for monthly barometer email updates and webinars.

Each month, the Purdue Center for Commercial Agriculture provides a short video analysis of the barometer results, available at https://purdue.ag/barometervideo, and for even more information, check out the Purdue Commercial AgCast podcast. It includes a detailed breakdown of each month’s barometer, in addition to a discussion of recent agricultural news that impacts farmers. Available now at https://purdue.ag/agcast.

The Ag Economy Barometer, Index of Current Conditions and Index of Future Expectations are available on the Bloomberg Terminal under the following ticker symbols: AGECBARO, AGECCURC and AGECFTEX.

About the Purdue University Center for Commercial Agriculture
The Center for Commercial Agriculture was founded in 2011 to provide professional development and educational programs for farmers. Housed within Purdue University’s Department of Agricultural Economics, the center’s faculty and staff develop and execute research and educational programs that address the different needs of managing in today’s business environment.

About CME Group
As the world’s leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest ratesequity indexesforeign exchangeenergyagricultural products and metals.  The company offers futures and options on futures trading through the CME Globex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec, EBS, TriOptima, and Traiana are trademarks of BrokerTec Europe LTD, EBS Group LTD, TriOptima AB, and Traiana, Inc., respectively. Dow Jones, Dow Jones Industrial Average, S&P 500, and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor’s Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc. All other trademarks are the property of their respective owners. 

Writer: Kami Goodwin, 765-494-6999, [email protected]  
Source: James Mintert, 765-494-7004, [email protected]

Related websites:
Purdue University Center for Commercial Agriculture: http://purdue.edu/commercialag
CME Group: http://www.cmegroup.com/

Photo Caption: Farmer sentiment rises as income prospects improve, concerns about key policy issues remain. (Purdue/CME Group Ag Economy Barometer/James Mintert) https://www.purdue.edu/uns/images/2020/dec-barometerLO.jpg

CME-G 

 

Cision View original content:http://www.prnewswire.com/news-releases/farmer-sentiment-rises-as-income-prospects-improve-concerns-about-key-policy-issues-remain-301200951.html

SOURCE CME Group

Ozop Energy Solutions Finalizes Name Change

WARWICK, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) —

Ozop Energy Solutions
. (OZSC), (“Ozop” or the “Company”), is pleased to announce that its name has officially been changed from Ozop Surgical Corp to Ozop Energy Solutions, Inc. This corporate action will take effect at the open of business on 1/5/2021. The symbol will remain OZSC.

The biggest transition our modern-day energy systems have ever seen is underway, and Ozop aims to be at the forefront of this development. Our name change supports our strategy as a broad renewable energy solutions company. “As we enter the new year, now is the perfect time to introduce our new name – Ozop Energy Solutions, Inc. – which reflects our recent strategic change from innovative surgical technologies, which struggled due to COVID-19, to entering the exploding energy storage market” stated Brian P Conway, Chief Executive Officer of OZSC. “The year 2020 was transformational for our company as we completed the acquisition of Power Conversion Technologies, Inc., resolved most of the company’s legacy debt, and executed a complete overhaul of the company’s management. Now that we are officially classified as an energy company, our team can move forward with additional acquisitions, new products, strategic partnerships, and new corporate and e-commerce websites. I look forward to sharing what we’ve been working on over the upcoming weeks.”

For more information on PCTI please follow on the link, www.pcti.com.

Please be aware that our social media accounts can be used from time to time for additional material events.

https://twitter.com/OzopEnergy

https://www.facebook.com/OzopEnergy/


The Waypoint Refinery (discord.com)

About Ozop Energy Solutions.

Ozop Energy Solutions (http://ozopenergy.com/) invents, designs, develops, manufactures, and distributes ultra-high power chargers, inverters, and power supplies for a wide variety of applications in the defense, heavy industrial, aircraft ground support, maritime and other sectors. Our strategy focuses on capturing a significant share of the rapidly growing renewable energy market as a provider of assets and infrastructure needed to store energy.

About Power Conversion Technologies, Inc.

Power Conversion Technologies, Inc. (www.pcti.com) invents, designs, develops, manufactures and distributes standard and custom power electronic solutions. Founded in 1991 and located in East Butler, Pennsylvania, the Company’s mission is to be the global leader for high power electronics with a standard of continued innovation.

Safe Harbor Statement

“This press release contains or may contain, among other things, certain forward-looking statements. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the company’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential” or similar expressions. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties, including those detailed in the company’s filings with the Securities and Exchange Commission. Actual results may differ significantly from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the company’s control). The company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.”

###

Investor Relations Contact

The Waypoint Refinery, LLC
845-397-2956
www.thewaypointrefinery.com



Footwear Brand Launches Celebros Search Solution to Power Site Search and Increase eCommerce Transactions

WOBURN, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based AI search solution, has announced that the New Balance online store in Indonesia will launch with Celebros Search as its search and product recommendations solution.

The New Balance online store in Indonesia, and its parent company Mitra Adiperkasa (MAP), have a long-standing relationship with Bridgeline. MAP is the leading lifestyle retailer in Indonesia with over 2,600 retail stores and a diversified portfolio that includes Skechers, Zara, Lacoste and many others.

The Celebros Search solution was selected because of its AI driven intelligent search and seamless integration with Magento, the eCommerce platform that powers many of MAP’s online stores. Celebros uses machine learning to understand user behavior and trends to provide customers with accurate and relevant results and recommendations. This will be especially important to the New Balance website because of its large and diverse product catalog.

According to Ari Kahn, CEO of Bridgeline, “We appreciate MAP and value their trust in our team and our products.” Mr. Kahn went on to add, “And we’re thrilled to add New Balance to our customer list. We believe our unique combination of advanced search and product recommendations will help New Balance drive more sales from their eCommerce websites.”

About Bridgeline Digital 

Bridgeline Digital, The Digital Engagement Company, helps customers maximize the performance of their omni-channel digital experience – from websites and intranets to online stores and campaigns. Bridgeline’s Unbound platform deeply integrates Web Content Management, eCommerce, Marketing Automation, Site Search, Community Portals, Social Media Management, Translation and Web Analytics to help organizations deliver digital experiences that attract, engage, nurture and convert their customers across all channels and streamline business operations. Headquartered in Woburn, Mass., Bridgeline has thousands of quality customers that range from small- and medium-sized organizations to Fortune 1000 companies. To learn more, please visit www.bridgeline.com or call (800) 603-9936. 

Contact: 

Jeremy LaDuque 
EVP of Marketing
Bridgeline Digital 
[email protected]



Atlas Growers Premium Products Now Available on the Medical Cannabis by Shoppers™ Portal

EDMONTON, Alberta, Jan. 05, 2021 (GLOBE NEWSWIRE) — Atlas Biotechnologies Inc. (“Atlas” or the “Company”) is pleased to announce the launch of Atlas’ medical cannabis products available through the Medical Cannabis by Shoppers online sales platform.

Atlas is proud to produce high quality, consistent cannabis products for the medical community. With the help of the Medical Cannabis by Shoppers team, patients will have access to our top of the line products offered in a variety of convenient formats to suit the needs of any patient.

Launched in December 2020, products include a selection of pre-rolls, flower, vape cartridges with terp sauces, 1:1 oil, CBD oil, and CBD extra strength oils following quickly. We are thrilled the rest of the Atlas Growers and Atlas Thrive products will launch by early 2021. Atlas understands many Canadians across the country are going through a very difficult time right now and are experiencing symptoms such as stress, anxiety, or sleepless nights. From our early days as a start-up in Edmonton, the goal of Atlas has always been to improve the quality of life for patients by creating cannabis products they can trust. The members of Atlas believe in this purpose and are dedicated to pursuing real, life changing research, along with the expertise to produce consistent, impactful and unique products that transform cannabis from a plant into a medicine.

Sheldon Croome, President & CEO of Atlas Biotechnologies Inc, notes “Atlas is proud to be partnered with Medical Cannabis by Shoppers Drug Mart Inc. to bring our rare, specialty cannabis cultivars to the medical community. We believe these products will better the lives of medical patients and will consistently deliver the outcome they need for their ailments. Atlas looks forward to launching further specialty formulations in our smokeless and transdermal products in early 2021.”


About Atlas Biotechnologies Inc. (“Atlas”) and Atlas Growers Ltd.

Atlas is based in Edmonton, Alberta, Canada and is federally licensed for cultivation and processing of cannabis products, with a focus on medical use markets. Atlas currently operates a purpose-built 38,000 sq. ft. facility and laboratory which has in-house capabilities to refine cannabis into distilled and isolated cannabinoid concentrates as well as specialized medical formulations in large volumes. In Europe, Atlas is constructing a 170,000 sq. ft. facility for indoor cultivation, and a 20,000 sq. ft. GMP-EU processing and production space for the manufacturing of unique formulations which will serve its existing and future European customers.

Atlas’ proprietary controlled environment cultivation system is designed to maximize production of the highest consistency and quality of cannabis products for medical use applications. In addition, Atlas is heavily focused on research and development and continues to solidify research collaborations with some of the world’s most prestigious post-secondary institutions including Harvard Medical School. Atlas continues towards its vision of improving lives by creating The World’s Most Trusted Cannabis Products™

Forward-Looking Information

This news release may contain “forward looking information” and “forward-looking statements” within the meaning of applicable Canadian securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. When used in this document, words such as “intends”, “plans”, “anticipates”, “potential”, “expects” and “scheduled”, are forward-looking statements. Forward-looking statements are subject to a wide range of business, market and economic risks and uncertainties, and although Atlas believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized and, as such, undue reliance should not be placed on forward-looking statements. Any number of factors can cause actual results to differ materially from those in the forward-looking statements. Except as required by law, Atlas disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

For further information, please contact:

Jeffrey R. Gossain, P. Eng. Christian Lopez
Chief Operating Officer  Corporate Affairs & Communications
Atlas Biotechnologies Inc. Atlas Biotechnologies Inc.
Phone: 780-784-5920 780-784-5920
Email: [email protected]  
Website: www.atlasgrowers.com